In 2024, the biotech industry will witness significant advancements, with AI playing a larger role in pharmaceutical processes. Through AI, more complex and sophisticated RNA technologies such as mRNAs, miRNAs, and siRNAs will be developed for immunotherapy and disease treatment. Bioprinting technology and tissue engineering are expected to revolutionize organ transplantation, while stem cell technologies aim to advance treatment for chronic diseases. The growing targeted protein degradation market is projected to accelerate drug discovery, while merger and acquisition activity will shape the industry.
Scaling Autonomous AI in Healthcare Without Compromising Clinical Trust
AI in healthcare will not fail because the models are weak. It will stall when leaders hesitate to redesign how decisions are made, measured and
